Audited information

Acquisition of the remaining shares of Companhia Brasileira de Bentonita

On 1 July 2015 Clariant acquired the remaining 50% shares of Companhia Brasileira de Bentonita (CBB) from the Brazilian-based company Geosol. This transaction was treated as a two step acquisition. Therefore, according to 3, the 50% shares already held were remeasured to fair value which resulted in a CHF 4 million gain recorded as »income from associates and in the income statement.

The acquisition of the remaining 50% shares for an amount of CHF 5 million paid in cash resulted in a gain on a bargain purchase in the amount of CHF 3 million, mainly from the remeasurement of mining rights, which was recognized in the income statement.

Acquisition of the de-icing activities from Kilfrost Ltd

On 30 September 2015 Clariant acquired from the British-based Kilfrost Ltd the de-icing activities in the United States, China and Korea, consisting mainly of customer relationships, know-how and inventories. Total consideration paid in cash was CHF 10 million and the provisional goodwill determined amounts to CHF 3 million.

Various smaller acquisitions were made in 2015 totalling a purchase price of CHF 7 million and generating a goodwill of CHF 1 million.

Acquisition of Plastichemix Industries in India

In April 2014, Clariant acquired Plastichemix Industries, a business in India, for a consideration of CHF 19 million mainly attributed to property, plant and equipment. The goodwill realised on that transaction amounted to CHF 5 million.

Acquisition of Aerochem in Scandinavia

In September 2014, Clariant acquired Aerochem, a Swedish- and Norwegian-based group, active in the de-icing and anti-icing fluids business. The purchase price mainly attributed to inventories amounts to CHF 15 million and the goodwill amounted to CHF 3 million.

Acquisition of VitaPac in China

In December 2014, Clariant acquired the Hong-Kong-based VitaPac, a specialist for healthcare packaging for a consideration of CHF 7 million and a goodwill of CHF 1.4 million. The acquisition complements the Medical Specialties Business Line of Clariant.

The impact from these acquisitions was not material to the result of the Group in 2015 and 2014.


The International Financial Reporting Standards (IFRS) are international accounting standards. VIEW ENTIRE GLOSSARY

Joint venture

Joint ventures are all activities in which Clariant is involved with another partner. The accounting method applied for joint ventures depends on the specific conditions of the participation. VIEW ENTIRE GLOSSARY


These are plastic additives in the form of granules with dyestuffs or other additives used to dye or alter the properties of natural plastic. VIEW ENTIRE GLOSSARY